Raymond James Financial Services Advisors, Inc. Embecta Corp. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 14, 2023	SELL	$23.07 - $32.77 $70,086 - $99,555	-3,038 Reduced 24.71%	9,259 $260,000
Q4 2022 Feb 08, 2023	SELL	$25.29 - $35.48 $117,244 - $164,485	-4,636 Reduced 27.38%	12,297 $310,000
Q3 2022 Oct 25, 2022	SELL	$24.0 - $33.42 $96,024 - $133,713	-4,001 Reduced 19.11%	16,933 $488,000
Q2 2022 Aug 12, 2022	BUY	$24.78 - $33.36 $518,744 - $698,358	20,934 New	20,934 $530,000

Others Institutions Holding EMBC

# of Institutions

405

Shares Held

51.1M

Call Options Held

162K

Put Options Held

61K

Black Rock Inc. New York, NY

9.19M
Shares

$186 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

7M
Shares

$142 Million
0.0% of portfolio
River Road Asset Management, LLC

3.48M
Shares

$70.3 Million
0.69% of portfolio
American Century Companies Inc Kansas City, MO

3.02M
Shares

$61.1 Million
0.03% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

2.73M
Shares

$55.2 Million
0.72% of portfolio

View Full List

About Embecta Corp.

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $1.17B
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

More about EMBC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account